News & Updates

Treatment with digoxin appears to reduce the risks of mortality and new-onset or worsening heart failure in patients with rheumatic heart disease (RHD), according to a study.

Patients with myocardial infarction (MI) and myocardial injury have a higher risk of developing future cardiovascular events, reveals a study.

Both chest compression-only (CCO) cardiopulmonary resuscitation (CPR) and standard CPR produce comparable survival and neurological outcomes in adults with out-of-hospital cardiac arrest (OHCA), reports a study.

Coeliac disease does not appear to elevate the risk of cardiovascular events, reveals a study, adding that previous associations may have reflected residual confounding rather than a direct pathogenic link.

In acute coronary syndrome (ACS) patients with depression who are undergoing cardiac rehabilitation, an improvement in depressive symptoms appear to be followed by an increase in walking fitness, as shown in a retrospective study.

Patients who underwent primary cancer site surgery are at greater risk of death from heart disease than the general population, reports a US study.

The use of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (ACEi/ARB) appears to reduce the risk of all-cause mortality and major adverse kidney events (MAKE) in very old adults who underwent dialysis for acute kidney injury (AKI), suggests a study.

In the prevention of stroke in patients with atrial fibrillation (AF), device-based left atrial appendage closure (LAAC) compares favourably with non–vitamin K antagonist oral anticoagulant (NOAC) therapy, with the added advantage of reduced non–procedure-related bleeding, according to the CHAMPION-AF trial.

In adolescents and young adults with repaired tetralogy of Fallot (rToF), home-based high-intensity interval training (HIIT) helps increase peak oxygen consumption and maximal workload without increasing the risk of adverse events, as shown in a study.

The use of clopidogrel for long-term antiplatelet monotherapy during the maintenance phase after percutaneous coronary intervention (PCI) results in reduced adverse cardiovascular and bleeding outcomes compared with aspirin, as shown in the secondary analysis of the HOST-EXAM study.